Furthermore, RNAi-mediated knock-down of Pea3 in mouse mammary tumor cells leads to decreased expression of multiple PEA3 gene targets with established proneoplastic roles, including Cox-2, vimentin, Cyclin D3, HER2/neu and several MMP genes [48]. This evidence concerns the gene ERBB2 and breast cancer.